Lynch Regenerative Medicine
Lynch Regenerative Medicine specializes in regenerative biotherapeutics focusing on platelet-derived growth factor (PDGF) for wound healing, soft tissue, and bone regeneration. The company demonstrates expertise in recombinant protein engineering, clinical development, and regulatory submission of PDGF-based therapies for medical, dental, and aesthetic applications. The leadership is comprised of experts in growth factor science and translational medicine with an extensive record of scientific publication, patents, and FDA approvals.
Industries
N/A
Lynch Regenerative Medicine
302 Innovation Drive, Suite 500, Franklin, TN 37067, United States
Products
A sterile, topical application containing high concentrations of recombinant growth factor for post-procedure skin care, with variants combined with hyaluronic acid for hydration.
A matrix combining recombinant growth factor with an osteoconductive scaffold for use in dental surgery to promote bone and soft tissue regeneration.
A topical gel with recombinant growth factor indicated for diabetic neuropathic ulcers, supporting fibroblast proliferation and tissue repair.
A sterile, topical application containing high concentrations of recombinant growth factor for post-procedure skin care, with variants combined with hyaluronic acid for hydration.
A matrix combining recombinant growth factor with an osteoconductive scaffold for use in dental surgery to promote bone and soft tissue regeneration.
A topical gel with recombinant growth factor indicated for diabetic neuropathic ulcers, supporting fibroblast proliferation and tissue repair.
Expertise Areas
- Growth factor-based regenerative medicine
- Wound healing therapeutics
- Aesthetic dermatology and skin rejuvenation
- Orthopedic and dental bone regeneration
Key Technologies
- Recombinant protein production
- Yeast-based expression systems
- Growth factor bioengineering
- Synthetic biomaterial scaffolds
Key People
News & Updates
Acquired exclusive rights to a recombinant growth factor-based wound healing gel, including assets and intellectual property for new clinical indications.
A review discussing the use of recombinant growth factor in tissue repair and regenerative medicine.
A randomized controlled trial comparing recombinant growth factor with autologous nanofat in enhancing recovery after cosmetic procedures.
Overview article discussing the historical and current role of platelet-derived growth factor in medical and aesthetic applications.
A peer-reviewed manuscript reviewing safety data for exogenously applied recombinant growth factor in medical and cosmetic uses.
Publication assessing the safety of repeated daily topical recombinant growth factor applications for skin wounds.
Acquired exclusive rights to a recombinant growth factor-based wound healing gel, including assets and intellectual property for new clinical indications.
A review discussing the use of recombinant growth factor in tissue repair and regenerative medicine.
A randomized controlled trial comparing recombinant growth factor with autologous nanofat in enhancing recovery after cosmetic procedures.
Overview article discussing the historical and current role of platelet-derived growth factor in medical and aesthetic applications.
A peer-reviewed manuscript reviewing safety data for exogenously applied recombinant growth factor in medical and cosmetic uses.
Publication assessing the safety of repeated daily topical recombinant growth factor applications for skin wounds.